Navigation Links
Agrivida Announces Dan Meagher as Chief Executive Officer
Date:11/18/2013

MEDFORD, Mass., Nov. 18, 2013 /PRNewswire/ -- Agrivida, Inc., a biotechnology company developing technologies for animal nutrition, cellulosic sugars from biomass, and regulated enzymes, announced today the appointment of Dan Meagher as Chief Executive Officer. Mr. Meagher joins Agrivida from Novus International, where he was President of Global Animal Nutrition Solutions and responsible for global sales, marketing, animal R&D, business development, customer service, logistics & distribution and local manufacturing blend facilities.  Prior to Novus, Dan was President of the Egg Products Further Processing Business Unit at MOARK, LLC, a producer and marketer of shell eggs and egg products, COO & Executive Vice President at MBA Poultry LLC, and Vice President at Purina Mills. "I'm extremely excited to be joining Agrivida, whose technology represents a paradigm shift in delivering performance to the animal nutrition industry at the lowest cost possible," stated Mr. Meagher.

Dan takes over at Agrivida as Mark Wong is named to Chairman of Agrivida's Board of Directors.  "We are extremely fortunate to have Dan Meagher joining Agrivida to lead our team into this next phase of development," said Mr. Wong. "Dan's experience in the animal nutrition area will be critical to driving the commercialization of Agrivida's technology in several areas." Mr. Wong assumes the chairman position following five years of service as Agrivida's CEO. During his tenure, Mr. Wong led the company through several successful rounds of financing and established strategic relationships with corn seed and biofuels companies.

Agrivida's new leadership team represents a broadening of the company's expertise, reflecting its growing pipeline of biotechnology products for the animal nutrition, biofuels, and industrial enzyme markets. 

About Agrivida, Inc.

Agrivida is developing and commercializing high-performance products that incorporate novel, regulated proteins precisely engineered for specific applications in a variety of markets, including animal feed and nutrition, bio-based fuels and chemicals, and industrial enzymes. Agrivida is transforming the economics of industrial and agricultural production through our pioneering use of regulated enzymes to develop higher-efficiency, lower-cost biomass feedstocks and intermediate inputs.


'/>"/>
SOURCE Agrivida, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. POET And Agrivida Sign Technology Collaboration Joint Development Agreement
2. QIAGEN Announces Third Co-Development Program for Companion Diagnostics Paired With Lillys Investigational Cancer Compounds
3. Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimers Disease Program
4. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
5. Ceres Announces Webcast of Fiscal Year 2013 Financial Results
6. Anterios, Inc., Announces Results of Consumer Survey Revealing Widespread Problem of Excessive Sweating and Desire for New Topical Botulinum Toxin Treatment
7. Cord Blood America Announces 2013 Third Quarter Financial Results
8. IPISC announces IP insurance for the Biotechnology/Pharma Industry
9. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
10. RXi Pharmaceuticals Announces the Start of Their First Phase 2 Study with RXI-109 for Treatment of Hypertrophic Scars in Conjunction with Scar Revision Surgery
11. LayerBio, Inc. Announces Launch; Signs Option for Technology from MIT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... UCHealth ( Aurora, Colorado ) ... nodule patient management. In addition to optimizing care coordination ... the lung, UCHealth looks to improve provider workflow by ... Stephanie Brown, RN , Thoracic Nurse Navigator, ... an Excel spreadsheet, which was extremely arduous and susceptible ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, ... study showed that aerosolized KL4 surfactant reduced lung ... preclinical animal model. The Company believes that these ... evidence that supports the role of KL4 surfactant ...
(Date:2/16/2017)... YORK , Feb. 16, 2017 Paradigm ... Series B financing, adding an additional $3M from New ... Mesa Verde Venture Partners and other strategic partners at ... towards further accelerating commercial adoption of their flagship Paradigm ... and expanding the Paradigm cancer registry. ...
Breaking Biology Technology:
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
Breaking Biology News(10 mins):